Related Experiment Videos
[Prognostic factors in acute nonlymphoid leukemias]
D Capelli1, A Tedeschi, M Montillo
1Clinica di Ematologia, Università, Ospedale Regionale di Torrette, Ancona.
Recenti Progressi in Medicina
|October 1, 1996
Summary
This study on acute non-lymphoid leukemia (ANLL) found age significantly impacts achieving complete remission. While many prognostic factors are debated, terminal deoxynucleotidyl transferase showed a significant association with prognosis.
Area of Science:
- Hematology
- Oncology
- Clinical Research
Context:
- Acute non-lymphoid leukemia (ANLL) prognosis is complex and influenced by numerous factors.
- Previous studies on ANLL prognostic indicators have yielded conflicting results.
- Identifying reliable prognostic markers is crucial for effective treatment strategies.
Purpose:
- To retrospectively assess various clinical and biological parameters influencing the prognosis of acute non-lymphoid leukemia (ANLL).
- To correlate diagnostic parameters with complete remission (CR) achievement, CR duration, and overall survival in ANLL patients.
- To clarify the prognostic significance of immunophenotyping in ANLL.
Summary:
- A retrospective analysis of 84 ANLL patients (1988-1994) examined age, fever, performance status, blood counts, extramedullary disease, bone marrow blastosis, immunophenotype, and cytogenetics.
- Age was the only parameter significantly associated with achieving complete remission.
- Terminal deoxynucleotidyl transferase was the sole immunophenotypic marker significantly linked to prognosis, despite ongoing controversy in ANLL literature.
Impact:
- This study highlights the controversial nature of prognostic factors in ANLL.
- Findings emphasize the importance of age and terminal deoxynucleotidyl transferase in predicting ANLL outcomes.
- Results aid in defining patient profiles for optimized post-remission treatment strategies.